{
  "abstract": "Immune escape remains a major barrier to durable cancer immunotherapy. Although checkpoint blockade has transformed cancer treatment, resistance commonly reflects broader tumor-intrinsic and microenvironmental programs that sustain immune dysfunction. At this interface, STAT3 emerges as a central organizing node. Beyond its canonical role in inflammatory and oncogenic signaling, STAT3 links tumor cell plasticity, immune suppression, and metabolic adaptation across the tumor ecosystem. In tumor cells, STAT3 promotes stemness, survival, checkpoint ligand expression, impaired antigen presentation, and immunosuppressive secretomes. In immune compartments, it drives regulatory T cell expansion, myeloid-derived suppressor cell accumulation, tumor-associated macrophage polarization, and dendritic cell dysfunction, thereby stabilizing an immune-resistant niche. STAT3 also reinforces immune escape through metabolic rewiring and multicellular feed-forward circuits. These features make STAT3 an attractive but challenging therapeutic target. Here, we discuss how STAT3 functions at the tumor-immune interface to coordinate immune escape and highlight therapeutic opportunities for targeting this axis in cancer.",
  "abstract_shown": true,
  "affiliations": [
    "Tianjin University of Traditional Chinese Medicine, College of Traditional Chinese Medicine",
    "Department of Colorectal Surgery, Tianjin Union Medical Center, The First Affiliated Hospital of Nankai University",
    "Tianjin Institute of Coloproctology, Tianjin Union Medical Center, The First Affiliated Hospital of Nankai University, Nankai University"
  ],
  "article_type": "review",
  "arxiv": null,
  "author_total": 3,
  "authors": [
    {
      "affs": [
        0
      ],
      "name": "Xuanya Cheng"
    },
    {
      "affs": [
        1,
        2
      ],
      "name": "Haoren Jing"
    },
    {
      "affs": [
        1,
        2,
        0
      ],
      "name": "Mingqing Zhang"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/9ndr97kj38y68.bib",
  "cited_by": 5,
  "doi": "10.3389/fimmu.2026.1850359",
  "fulltext_url": null,
  "id": "9ndr97kj38y68",
  "issns": [
    "1664-3224"
  ],
  "landing_url": "https://doi.org/10.3389/fimmu.2026.1850359",
  "language": "en",
  "licence": "CC-BY",
  "licence_label": "CC BY",
  "licence_source": "journal",
  "licence_url": "https://creativecommons.org/licenses/by/4.0/",
  "metadata_licence": null,
  "native_subjects": [
    [
      "openalex",
      "2403|Cytokine Signaling Pathways and Interactions"
    ]
  ],
  "openalex": "W7161636841",
  "pdf_url": null,
  "pmcid": "PMC13226528",
  "pmid": "42238578",
  "published": "2026-05-19",
  "publisher": "Frontiers Media",
  "ris": "https://research.draconitic.com/paper/9ndr97kj38y68.ris",
  "sources": [
    {
      "first_seen": "2026-11-07T13:20:53Z",
      "native_id": "W7161636841",
      "source": "openalex",
      "url": "https://doi.org/10.3389/fimmu.2026.1850359"
    }
  ],
  "subjects": [
    {
      "field": "biology",
      "origin": "openalex:2403|Cytokine Signaling Pathways and Interactions",
      "subfield": "immunology"
    }
  ],
  "title": "STAT3 at the tumor-immune interface: mechanisms of immune escape and therapeutic opportunities",
  "title_text": "STAT3 at the tumor-immune interface: mechanisms of immune escape and therapeutic opportunities",
  "type": "peer-reviewed",
  "updated_at": "2026-11-09T13:21:11Z",
  "url": "https://research.draconitic.com/paper/9ndr97kj38y68",
  "venue": "Frontiers in Immunology",
  "versions": []
}